CS
ZBH icon

Cannell & Spears’s Zimmer Biomet ZBH Stock Holding History

Cannell & Spears’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,751
Closed -$247K – 445
2025
Q4 		$247K Hold
2,751
– – ﹤0.01% 372
2025
Q3 		$271K Sell
2,751
-97
-3% -$9.61K 0.01% 353
2025
Q2 		$260K Sell
2,848
-70
-2% -$6.77K 0.01% 341
2025
Q1 		$330K Buy
2,918
+3
+0.1% +$321 0.01% 320
2024
Q4 		$308K Sell
2,915
-1,958
-40% -$210K 0.01% 335
2024
Q3 		$526K Buy
4,873
+26
+0.5% +$2.84K 0.01% 296
2024
Q2 		$526K Sell
4,847
-19,467
-80% -$2.29M 0.01% 267
2024
Q1 		$3.21M Buy
+24,314
New +$3.04M 0.07% 150

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cannell & Spears's ZBH Position: Q1 2026 in Review

Cannell & Spears sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2,751 shares — an estimated $247K sold.

Cannell & Spears first reported a position in ZBH in Q1 2024 and held it in 8 quarters. The position peaked at $3.21M in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Cannell & Spears reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Cannell & Spears sold 2,751 Zimmer Biomet shares in Q1 2026, an estimated $247K.
  • Cannell & Spears first reported a position in Zimmer Biomet in Q1 2024 and held it in 8 quarters.
  • Cannell & Spears's Zimmer Biomet position peaked at $3.21M in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.